Treprostinil palmitil

N/A

Report date: 2026/05/05 20:00:16

Base Information

Drug NameTreprostinil palmitil
Drug Alias NameINS-1009
ClassificationSmall molecules
Mechanisms of ActionProstanoid IP receptor agonistsPlatelet aggregation inhibitors
TargetsProstanoid IP receptor
Therapy Area/IndicationsLung Diseases, InterstitialPulmonary Arterial HypertensionHypertension, Pulmonary +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[27] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesInsmed Inc
China Registration ClassN/A

Develop Information

Active CompaniesInsmed Inc
Inactive CompaniesN/A
Active IndicationsLung Diseases, InterstitialPulmonary Arterial HypertensionHypertension, Pulmonary +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A